| DAA703 |
Wall increases in thickness |
Physiological |
left ventricle |
Human |
— |
— |
|
| DAA1349 |
WD repeat and FYVE domain containing 4 |
Molecular |
hematological system |
Mouse |
Wdfy4 |
10.0% Decrease Gene Expression Level |
|
| DAA250 |
WD repeat and SOCS box-containing 2 |
Molecular |
brain |
Human |
WSB2 |
5.0% Decrease Gene Expression Level |
|
| DAA436 |
WD repeat domain 12 |
Molecular |
skeletal muscle |
Human |
WDR12 |
3.0% Decrease Gene Expression Level |
|
| DAA1570 |
WD repeat domain 31 |
Molecular |
lung |
Mouse |
Wdr31 |
11.0% Increase Gene Expression Level |
|
| DAA1837 |
WD repeat domain 4 |
Molecular |
muscle |
Mouse |
Wdr4 |
5.0% Decrease Gene Expression Level |
|
| DAA846 |
Weakening of intestinal wall |
Physiological |
large intestine |
Human |
— |
— |
|
| DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
| DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
| DAA730 |
White matter volume decreases |
Physiological |
white matter |
Human |
— |
— |
|
| DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA1283 |
wingless related MMTV integration site 10a |
Molecular |
cochlea |
Mouse |
Wnt10a |
16.0% Increase Gene Expression Level |
|
| DAA1338 |
wingless-related MMTV integration site 4 |
Molecular |
hematological system |
Mouse |
Wnt4 |
44.0% Increase Gene Expression Level |
|
| DAA1308 |
wingless-related MMTV integration site 5A |
Molecular |
hematological system |
Mouse |
Wnt5a |
34.0% Increase Gene Expression Level |
|
| DAA1658 |
WNT1 inducible signaling pathway protein 1 |
Molecular |
lung |
Mouse |
Wisp1 |
20.0% Decrease Gene Expression Level |
|
| DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
WISP2 |
23.5% Decrease DNA Methylation |
|
| DAA2391 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
dermis |
Human |
WISP2 |
17.7% Decrease DNA Methylation |
|
| DAA1003 |
Wrinkles |
Physiological |
skin |
Human |
— |
— |
|
| DAA1468 |
WW, C2 and coiled-coil domain containing 1 |
Molecular |
kidney |
Mouse |
Wwc1 |
11.0% Increase Gene Expression Level |
|
| DAA251 |
WW domain containing transcription regulator 1 |
Molecular |
brain |
Human |
WWTR1 |
24.0% Increase Gene Expression Level |
|
| DAA353 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
7.0% Increase Gene Expression Level |
|
| DAA586 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
6.0% Increase Gene Expression Level |
|
| DAA1853 |
X-linked inhibitor of apoptosis |
Molecular |
skeletal muscle |
Mouse |
Xiap |
13.0% Decrease Gene Expression Level |
|
| DAA1872 |
X-linked myotubular myopathy gene 1 |
Molecular |
skeletal muscle |
Mouse |
Mtm1 |
14.0% Decrease Gene Expression Level |
|
| DAA255 |
zer-1 homolog (C. elegans) |
Molecular |
brain |
Human |
ZER1 |
16.0% Decrease Gene Expression Level |
|